2019
DOI: 10.15252/emmm.201910567
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of phosphatidylinositol 3‐kinase α (PI3Kα) prevents heterotopic ossification

Abstract: Heterotopic ossification (HO) is the pathological formation of ectopic endochondral bone within soft tissues. HO occurs following mechanical trauma, burns, or congenitally in patients suffering from fibrodysplasia ossificans progressiva (FOP). FOP patients carry a conserved mutation in ACVR1 that becomes neomorphic for activin A responses. Here, we demonstrate the efficacy of BYL719, a PI3Kα inhibitor, in preventing HO in mice. We found that PI3Kα inhibitors reduce SMAD, AKT, and mTOR/S6K activities. Inhibitio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 48 publications
(91 reference statements)
1
23
0
Order By: Relevance
“…The western blot results showed that the nesfatin-1-induced osteogenic differentiation of TDSCs was significantly suppressed by rapamycin. In vivo , as expected, rapamycin suppressed heterotopic bone formation when compared with the HO group, which has been previously reported ( Hino et al, 2018 ; Valer et al, 2019 ). Nesfatin-1 increased heterotopic bone formation and activation of mTOR signaling in the tendon, both decreased by rapamycin.…”
Section: Discussionsupporting
confidence: 88%
“…The western blot results showed that the nesfatin-1-induced osteogenic differentiation of TDSCs was significantly suppressed by rapamycin. In vivo , as expected, rapamycin suppressed heterotopic bone formation when compared with the HO group, which has been previously reported ( Hino et al, 2018 ; Valer et al, 2019 ). Nesfatin-1 increased heterotopic bone formation and activation of mTOR signaling in the tendon, both decreased by rapamycin.…”
Section: Discussionsupporting
confidence: 88%
“…Additionally, the PI3K/AKT/GSK3 pathway has been linked to SMAD1 levels in murine osteoblasts, affecting bone homeostasis and regulation [76]. Recently, PI3K signalling was also linked to HO and FOP since inhibitors of PI3Kα prevented heterotopic ossification in vivo [77]. The Rho/ROCK pathway, a regulator of mechanosensing, cell motility, and cytoskeleton organisation, has also been related to ACVR1.…”
Section: Fibrodysplasia Ossificans Progressivamentioning
confidence: 99%
“…Moreover, BMP-7 regulated the differentiation ability of MSC in the formation of heterotopic ossification of soft tissue through the Wnt/β-catenin pathway (Fu et al, 2017). In fibrodysplasia ossificans progressive disease, mTOR (Agarwal et al, 2016) and NF-κB/MAPK (Barruet et al, 2018) were related with the formation of muscle heterotopic ossification under crosstalk with BMP signaling, and BMPs together with SMAD, AKT, and mTOR/S6K signaling could prevent heterotopic ossification progress when the activity of PI3Kα was inhibited (Valer et al, 2019). RhoA-BMPs (Mu et al, 2013) and CGRP-SP-BMP-2 (Tuzmen et al, 2018) signaling also regulated heterotopic ossification progress in dystrophic muscle and Achilles tendon of mice, respectively.…”
Section: Discussionmentioning
confidence: 99%